179 related articles for article (PubMed ID: 15509616)
1. A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B.
Capilla J; Mayayo E; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2004 Dec; 54(6):1092-5. PubMed ID: 15509616
[TBL] [Abstract][Full Text] [Related]
2. Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis.
Ortoneda M; Capilla J; Pastor FJ; Serena C; Guarro J
Diagn Microbiol Infect Dis; 2004 Dec; 50(4):247-51. PubMed ID: 15582297
[TBL] [Abstract][Full Text] [Related]
3. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole.
Barbaric D; Shaw PJ
Med Pediatr Oncol; 2001 Aug; 37(2):122-5. PubMed ID: 11496350
[TBL] [Abstract][Full Text] [Related]
4. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata.
Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113
[TBL] [Abstract][Full Text] [Related]
6. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
7. Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis.
Adler-Moore JP; Olson JA; Proffitt RT
J Antimicrob Chemother; 2004 Dec; 54(6):1096-102. PubMed ID: 15509617
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
Khan MA; Nasti TH; Owais M
J Antimicrob Chemother; 2005 Oct; 56(4):726-31. PubMed ID: 16126780
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
10. Combined antifungal therapy in a murine infection by Candida glabrata.
Mariné M; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis.
Bocanegra R; Najvar LK; Hernandez S; McCarthy DI; Graybill JR
Antimicrob Agents Chemother; 2005 Dec; 49(12):5139-41. PubMed ID: 16304187
[TBL] [Abstract][Full Text] [Related]
13. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
Husain S; Muñoz P; Forrest G; Alexander BD; Somani J; Brennan K; Wagener MM; Singh N
Clin Infect Dis; 2005 Jan; 40(1):89-99. PubMed ID: 15614697
[TBL] [Abstract][Full Text] [Related]
14. Experimental murine scedosporiosis: histopathology and azole treatment.
Rodríguez MM; Pastor FJ; Salas V; Calvo E; Mayayo E; Guarro J
Antimicrob Agents Chemother; 2010 Sep; 54(9):3980-4. PubMed ID: 20547805
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Schwarz P; Dromer F; Lortholary O; Dannaoui E
Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy in treatment of murine infection by Fusarium solani.
Ruíz-Cendoya M; Mariné M; Guarro J
J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
Chakraborty KK; Naik SR
J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
[TBL] [Abstract][Full Text] [Related]
18. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
Haynes RR; Connolly PA; Durkin MM; LeMonte AM; Smedema ML; Brizendine E; Wheat LJ
J Infect Dis; 2002 Jun; 185(12):1830-2. PubMed ID: 12085335
[TBL] [Abstract][Full Text] [Related]
19. Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.
Rodríguez MM; Calvo E; Serena C; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2009 May; 53(5):2153-5. PubMed ID: 19223617
[TBL] [Abstract][Full Text] [Related]
20. Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans.
Brime B; Molero G; Frutos P; Frutos G
Eur J Pharm Sci; 2004 Aug; 22(5):451-8. PubMed ID: 15265515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
